Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.

Mirza Y, O'Neill J, Smith EA, Russell A, Smith JM, Banerjee SP, Bhandari R, Boyd C, Rose M, Ivey J, Renshaw PF, Rosenberg DR.

J Child Neurol. 2006 Feb;21(2):106-11.

PMID:
16566872
2.

Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.

Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR.

Biol Psychiatry. 2000 Feb 1;47(3):174-82.

PMID:
10682215
3.

Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.

Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ.

J Child Neurol. 2001 Sep;16(9):636-41.

PMID:
11575601
4.

Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2003 Dec 15;54(12):1399-405.

PMID:
14675804
5.

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ.

J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53.

PMID:
15322418
6.

Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.

Zhu Y, Fan Q, Han X, Zhang H, Chen J, Wang Z, Zhang Z, Tan L, Xiao Z, Tong S, Maletic-Savatic M, Li Y.

J Affect Disord. 2015 Jun 1;178:193-200. doi: 10.1016/j.jad.2015.03.008. Epub 2015 Mar 14.

PMID:
25819113
7.

Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness.

Fallucca E, MacMaster FP, Haddad J, Easter P, Dick R, May G, Stanley JA, Rix C, Rosenberg DR.

Arch Gen Psychiatry. 2011 May;68(5):527-33. doi: 10.1001/archgenpsychiatry.2011.36.

8.

Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders.

Mohamed MA, Smith MA, Schlund MW, Nestadt G, Barker PB, Hoehn-Saric R.

Psychiatry Res. 2007 Nov 15;156(2):175-9. Epub 2007 Sep 29.

PMID:
17904826
9.

An MRI and proton spectroscopy study of the thalamus in children with autism.

Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R, Keshavan MS, Stanley JA.

Psychiatry Res. 2008 Jul 15;163(2):97-105. doi: 10.1016/j.pscychresns.2007.12.002. Epub 2008 May 27.

10.

Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study.

Mory SB, Li LM, Guerreiro CA, Cendes F.

Epilepsia. 2003 Nov;44(11):1402-5.

11.

Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.

Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP, Easter P, Rose M, Michalopoulou GA, Rosenberg DR.

Am J Psychiatry. 2008 Oct;165(10):1299-307. doi: 10.1176/appi.ajp.2008.08010033. Epub 2008 Apr 15.

PMID:
18413702
12.

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.

O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.

Neuroimage. 2004 Apr;21(4):1781-9.

13.

Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.

Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, Desmond P, Pantelis C.

Schizophr Bull. 2003;29(4):831-43.

PMID:
14989417
14.

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.

Psychiatry Res. 2004 Jul 30;131(2):95-105.

PMID:
15313516
15.

Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy.

Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ.

Biol Psychiatry. 2000 Aug 15;48(4):294-300. Erratum in: Biol Psychiatry 2001 Aug 15;50(4):312.

PMID:
10960160
16.

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.

Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC.

Schizophr Res. 2001 Oct 1;52(1-2):87-99.

PMID:
11595395
17.

Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.

Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW.

Br J Psychiatry. 1995 Nov;167(5):629-34.

PMID:
8564319
18.

Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: a functional magnetic resonance imaging study.

Gilbert AR, Akkal D, Almeida JR, Mataix-Cols D, Kalas C, Devlin B, Birmaher B, Phillips ML.

J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):936-44. doi: 10.1097/CHI.0b013e3181b2163c.

PMID:
19625980
19.

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.

Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.

Psychiatry Res. 2003 Jun 30;123(2):87-100.

PMID:
12850248
20.

Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR.

Arch Gen Psychiatry. 2000 May;57(5):449-56.

PMID:
10807485

Supplemental Content

Support Center